Tumor-associated macrophages (TAMs) may also play a role in the tumor microenvironment [20], but studies on (CD68+) TAM infiltrate as a biomarker in the neoadjuvant setting are scarce [21, 22]. The gene discussed is CD68; the disease is neoplasm.